Author:
Sai Sivapuram Madhava, ,Nagarathna Raghuram,Anand Akshay,Patil Suchitra,Singh Amit,Ramarao Nagendra Hongasandra, , , , , , ,
Abstract
Abuse of legal substances in India includes alcohol and tobacco, which are the major risk factors for various non-communicable diseases and deaths. The current pandemic has identified tobacco consumption as a risk factor for COVID-19, highlighting the need to control substance abuse. The objective of this study was to estimate the prevalence of substance abuse in India and discuss the cost-effective public health strategies (such as yoga) to alleviate COVID-related anxiety in order to prevent substance abuse and its associated co-morbidities such as type 2 diabetes mellitus. This study reports the data on tobacco and alcohol abuse from a nationwide randomized two-arm diabetes control trial (Niyantrita Madhumeha Bharata, 2017) conducted by the Indian Yoga Association (IYA) through Swami Vivekananda Yoga Anusandhana Samsthana (S-VYASA), Bengaluru. Data of 30,354 participants who abuse tobacco and 30,159 participants who abuse alcohol were collected all over India. The prevalence is estimated at around 8.7% for alcohol abuse and 7.9% for tobacco abuse, Arunachal Pradesh state ranking the highest regarding both alcohol and tobacco abuse, while the Tripura state ranked the lowest. School and college-based mandatory yoga programs need to be implemented to prevent the increase of substance abuse in India to alleviate the psychosocial stress of adolescents and college-going students, besides the installation of the mindfulness-based diabetes yoga protocol (DYP) in the wellness centers of Ayushman Bharat.
Publisher
S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L
Reference48 articles.
1. 1. Atzendorf J, Rauschert C, Seitz NN, Lochbühler K, Kraus L. The Use of Alcohol, Tobacco, Illegal Drugs and Medicines. Dtsch Arztebl Int. 2019;116(35-36):577-584.
2. 2. Stockings E, Hall WD, Lynskey M, Morley KI, Reavley N, Strang J, Patton G, Degenhardt L. Prevention, early intervention, harm reduction, and treatment of substance use in young people. Lancet Psychiatry. 2016;3(3):280-96.
3. 3. José BPS, Corrêa RA, Malta DC, Passos VMA, França EB, Teixeira RA, Camargos PAM. Mortality and disability from tobacco- related diseases in Brazil, 1990 to 2015. Rev Bras Epidemiol. 2017;20(Suppl 01):75-89.
4. 4. World Health Organization (WHO). WHO factsheet on tobacco use. Geneva: World Health Organization;2018. [cited 2020Apr23]. Available from: https://apps.who.int/iris/bitstream/handle/10665/272672/wntd_2018_india_fs.pdf?sequence=1
5. 5. World Health Organization (WHO). WHO report on the global tobacco epidemic, 2013. Enforcing bans on tobacco advertising, promotion and sponsorship. Geneva: World Health Organization; 2013. [cited 2020Apr23]. Available from: http://apps.who.int/iris/ bitstream/10665/85380/1/9789241505871_eng. pdf ?ua=1
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献